UNSPSC 85812314: Introduction of other antineoplastic into lower gi, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other antineoplastic into lower gi, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0H305

UNSPSC 85812314, Introduction of other antineoplastic into lower GI, percutaneous approach, is a Commodity code that shows minimal alignment with recent state and local procurement activity. The code nominally describes a specific clinical procedure—percutaneous chemotherapy infusion into the lower gastrointestinal tract—yet the recent opportunities posted under this code span telehealth, occupational health, cancer screening, emergency medical services, behavioral health, nursing home operations, and orthotic services, none of which match the narrow clinical scope the code name suggests. Inland Empire Health Plan's RFI for virtual urgent care (RFI 2607426, due October 31, 2026) and DeKalb County's vague medical services RFP (due November 12, 2026) represent the only loosely healthcare-adjacent solicitations, but neither targets the specific procedure named in the code.

State and local issuers tagging work under this code include health plans, county government, state health authorities, and county health systems across California, Georgia, and Nevada. The recent posting pattern reflects a mismatch between code assignment and actual procurement intent: Nevada Health Authority has posted multiple RFPs—including the large Program of All Inclusive Care for the Elderly (PACE) contract (RFP 41NHA-S4038, due December 10, 2026) serving seniors in Clark, Washoe, and rural counties at fixed monthly capitation rates ranging from $4,532 to $8,804 per member—yet PACE operations bear no relationship to percutaneous antineoplastic therapy. Similarly, San Mateo County's cancer registry and retinal screening device procurements (due October 12 and November 6, 2026, respectively) address support services and diagnostic equipment, not oncologic infusion procedures. The code appears to be a data-quality issue in state and local procurement tagging rather than a live market signal for the clinical service it nominally describes. Businesses evaluating this code should verify actual opportunity scope before investing in pursuit strategy, as assignment to this Commodity code does not reliably predict what state and local buyers are actually soliciting.